{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["EGFR", "Quinazolinone", "anticancer", "cytotoxicity", "docking"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33357002", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "10"}, "DateRevised": {"Year": "2022", "Month": "01", "Day": "18"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1080/14756366.2020.1854243"], "Journal": {"ISSN": "1475-6374", "JournalIssue": {"Volume": "36", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Dec"}}, "Title": "Journal of enzyme inhibition and medicinal chemistry", "ISOAbbreviation": "J Enzyme Inhib Med Chem"}, "ArticleTitle": "Synthesis of some quinazolinones inspired from the natural alkaloid L<i>-</i>norephedrine as EGFR inhibitors and radiosensitizers.", "Pagination": {"StartPage": "218", "EndPage": "237", "MedlinePgn": "218-237"}, "Abstract": {"AbstractText": ["A set of quinazolinones synthesized by the aid of L-norephedrine was assembled to generate novel analogues as potential anticancer and radiosensitizing agents. The new compounds were evaluated for their cytotoxic activity against MDA-MB-231, MCF-7, HepG-2, HCT-116 cancer cell lines and EGFR inhibitory activity. The most active compounds <b>5</b> and <b>6</b> were screened against MCF-10A normal cell line and displayed lower toxic effects. They proved their relative safety with high selectivity towards MDA-MB-231 breast cancer cell line. Measurement of the radiosensitizing activity for <b>5</b> and <b>6</b> revealed that they could sensitize the tumour cells after being exposed to a single dose of 8\u2009Gy gamma radiation. Compound <b>5</b> was able to induce apoptosis and arrest the cell cycle at the G2-M phase. Molecular docking of <b>5</b> and <b>6</b> in the active site of EGFR was performed to gain insight into the binding interactions with the key amino acids."]}, "AuthorList": [{"Identifier": ["0000-0003-4250-0452"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt."}], "LastName": "Ghorab", "ForeName": "Mostafa M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, Alexandria University, Alexandria, Egypt."}], "LastName": "Abdel-Kader", "ForeName": "Maged S", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Medicinal, Aromatic and Poisonous Plants Research Center (MAPPRC), College of Pharmacy, King Saud University, Riyadh, Saudi Arabia."}], "LastName": "Alqahtani", "ForeName": "Ali S", "Initials": "AS"}, {"Identifier": ["0000-0001-6562-9828"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Drug Radiation Research, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt."}], "LastName": "Soliman", "ForeName": "Aiten M", "Initials": "AM"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "J Enzyme Inhib Med Chem", "NlmUniqueID": "101150203", "ISSNLinking": "1475-6366"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Quinazolinones"}, {"RegistryNumber": "0", "NameOfSubstance": "Radiation-Sensitizing Agents"}, {"RegistryNumber": "33RU150WUN", "NameOfSubstance": "Phenylpropanolamine"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "EGFR protein, human"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "ErbB Receptors"}], "MeshHeadingList": [{"QualifierName": ["drug effects", "radiation effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects", "radiation effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["chemical synthesis", "metabolism", "pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["cytology", "drug effects", "radiation effects"], "DescriptorName": "Epithelial Cells"}, {"QualifierName": ["antagonists & inhibitors", "chemistry", "metabolism"], "DescriptorName": "ErbB Receptors"}, {"QualifierName": [], "DescriptorName": "Gamma Rays"}, {"QualifierName": [], "DescriptorName": "HCT116 Cells"}, {"QualifierName": [], "DescriptorName": "Hep G2 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": [], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemistry", "metabolism", "pharmacology"], "DescriptorName": "Phenylpropanolamine"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "Protein Conformation, alpha-Helical"}, {"QualifierName": [], "DescriptorName": "Protein Conformation, beta-Strand"}, {"QualifierName": [], "DescriptorName": "Protein Interaction Domains and Motifs"}, {"QualifierName": ["chemical synthesis", "metabolism", "pharmacology"], "DescriptorName": "Quinazolinones"}, {"QualifierName": ["chemical synthesis", "metabolism", "pharmacology"], "DescriptorName": "Radiation-Sensitizing Agents"}, {"QualifierName": [], "DescriptorName": "Stereoisomerism"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}], "CoiStatement": "No potential conflict of interest was reported by the author(s)."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Peitzsch C, Perrin R, Hill RP, et al. . Hypoxia as a biomarker for radioresistant cancer stem cells. Int J Radiat Biol 2014;90:636\u201352.", "ArticleIdList": ["24844374"]}, {"Citation": "Sugrue T, Lowndes NF, Ceredig R.. Hypoxia enhances the radioresistance of mouse mesenchymal stromal cells. Stem Cells 2014;32:2188\u2013200.", "ArticleIdList": ["24578291"]}, {"Citation": "Wang X-M, Xu J, Li Y-P, et al. . Synthesis and anticancer activity evaluation of a series of [1,2,4]triazolo[1,5-a]pyridinylpyridines in\u00a0vitro and in\u00a0vivo. Eur J Med Chem 2013;67:243\u201351.", "ArticleIdList": ["23871904"]}, {"Citation": "Holohan C, Van Schaeybroeck S, Longley DB, Johnston P.. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 2013;13:714\u201326.", "ArticleIdList": ["24060863"]}, {"Citation": "Xie L, Bourne PE.. Developing multi-target therapeutics to fine-tune the evolutionary dynamics of the cancer ecosystem. Front Pharmacol 2015;6:209\u201314.", "ArticleIdList": ["PMC4585080", "26441664"]}, {"Citation": "El Ella DAA, Ghorab MM, Heiba HI, Soliman AM.. Synthesis of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety for evaluation as anticancer and radiosensitizing agents. Med Chem Res 2012;21:2395\u2013407."}, {"Citation": "Hubbard SR, Miller W.. Receptor tyrosine kinases: mechanisms of activation and signaling. Curr Opin Cell Biol 2007;19:117\u201323.", "ArticleIdList": ["PMC2536775", "17306972"]}, {"Citation": "Regad T. Targeting RTK signaling pathways in cancer. Cancers 2015;7:1758\u201384.", "ArticleIdList": ["PMC4586793", "26404379"]}, {"Citation": "Baker SJ, Reddy EP, Medicine P.. Targeted inhibition of kinases in cancer therapy. MT Sinai J Med 2010;77:573\u201386.", "ArticleIdList": ["PMC3058778", "21105121"]}, {"Citation": "Flynn JF, Wong C, Wu JM.. Anti-EGFR therapy: mechanism and advances in clinical efficacy in breast cancer. J Oncol 2009;2009:526963.", "ArticleIdList": ["PMC2668926", "19390622"]}, {"Citation": "Yewale C, Baradia D, Vhora I, et al. . Epidermal growth factor receptor targeting in cancer: a review of trends and strategies. Biomaterials 2013;34:8690\u2013707.", "ArticleIdList": ["23953842"]}, {"Citation": "Ghorab MM, Alqahtani AS, Soliman AM, Askar AA.. Novel N-(substituted) thioacetamide quinazolinone benzenesulfonamides as antimicrobial agents. Int J Nanomedicine 2020;15:3161\u201380.", "ArticleIdList": ["PMC7211327", "32440116"]}, {"Citation": "Soliman AM, Karam HM, Mekkawy MH, Ghorab MM.. Antioxidant activity of novel quinazolinones bearing sulfonamide: potential radiomodulatory effects on liver tissues via NF-\u03baB/ PON1 pathway . Eur J Med Chem 2020;197:112333.", "ArticleIdList": ["32361176"]}, {"Citation": "Soliman AM, Ghorab MM, Bua S, Supuran CT.. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: synthesis, biological evaluation and radiosensitizing activity. Eur J Med Chem 2020;200:112449.", "ArticleIdList": ["32485534"]}, {"Citation": "Soliman AM, Karam HM, Mekkawy MH, Higgins M, et al. . Radiomodulatory effect of a non-electrophilic NQO1 inducer identified in a screen of new 6, 8-diiodoquinazolin-4(3H)-ones carrying a sulfonamide moiety . Eur J Med Chem 2020;200:112467.", "ArticleIdList": ["PMC7355233", "32502866"]}, {"Citation": "Marzaro G, Guiotto A, Chilin A.. Quinazoline derivatives as potential anticancer agents: a patent review (2007\u20132010). Expert Opin Ther Pat 2012;22:223\u201352.", "ArticleIdList": ["22404097"]}, {"Citation": "Wu P, Nielsen TE, Clausen MH.. Tips. FDA-approved small-molecule kinase inhibitors. Trends Pharmacol Sci 2015;36:422\u201339.", "ArticleIdList": ["25975227"]}, {"Citation": "Ugale VG, Bari SB.. Quinazolines: new horizons in anticonvulsant therapy. Eur J Med Chem 2014;80:447\u2013501.", "ArticleIdList": ["24813877"]}, {"Citation": "Karamouzis MV, Grandis JR, Argiris A.. Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas. JAMA 2007;298:70\u201382.", "ArticleIdList": ["17609492"]}, {"Citation": "Ghorab MM, Alsaid MS, Soliman AM.. Dual EGFR/HER2 inhibitors and apoptosis inducers: New benzo[g]quinazoline derivatives bearing benzenesulfonamide as anticancer and radiosensitizers. Bioorg Chem 2018;80:611\u201320.", "ArticleIdList": ["30041137"]}, {"Citation": "Soliman AM, Ghorab MM.. Exploration of N-alkyl-2-[(4-oxo-3-(4-sulfamoylphenyl)-3,4-dihydroquinazolin-2-yl)thio]acetamide derivatives as anticancer and radiosensitizing agents . Bioorg Chem 2019;88:102956.", "ArticleIdList": ["31054432"]}, {"Citation": "Lee YC, Chen YY, Lin JS, Chen YW, et al. . Stereoselective synthesis of (1R, 2S)-norephedrine by recombinant whole-cell biocatalysts coupling acetohydroxyacid synthase I and \u03c9-transaminase. Process Biochem 2018;73:74\u201381."}, {"Citation": "Meadows M. FDA issues public health advisory on phenylpropanolamine in drug products. FDA Consum 2001;35:9.", "ArticleIdList": ["11930934"]}, {"Citation": "Groeper JA, Hitchcock SR, Ferrence GM.. A scalable and expedient method of preparing diastereomerically and enantiomerically enriched pseudonorephedrine from norephedrine. Tetrahedron Asymmetry 2006;17:2884\u20139."}, {"Citation": "Alsaid MS, Ghorab MM, Alqasoumi SI, Abdel-Kader MS.. Semisynthesis of some novel thiourea and carbamimidothioic acid derivatives using natural alkaloid L-norephedrine and their anticancer activity. Russ J Bioorganic Chem 2016;42:567\u201373."}, {"Citation": "El-Hiti GA, Hussain A, Hegazy AS, Alotaibi MH.. Thioxoquinazolines: synthesis, reactions and biological activities. J Sulfur Chem 2011;32:361\u201395."}, {"Citation": "Ghorab MM, Alsaid MS, Shahat AA.. Synthesis of some sulfonamide incorporating enaminone, quinolone moieties and thiazoloquinazoline derivative induce the cytoprotective enzyme NAD (P) H: quinone oxidoreductase 1. Biomed Res 2016;27:1."}, {"Citation": "Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55\u201363.", "ArticleIdList": ["6606682"]}, {"Citation": "Ghorab MM, Al-Said MS, Abdel-Kader MS, et al. . Absolute configuration of (1S,2S)-3-methyl-2-phenyl-2,3-dihydro-thia-zolo[2,3-b]quinazolin-5-one . Acta Cryst E 2012;68:o927\u20138.", "ArticleIdList": ["PMC3343911", "22589992"]}, {"Citation": "Hassan RM, Abd-Allah WH, Salman AM, et al. . Design, synthesis and anticancer evaluation of novel 1,3-benzodioxoles and 1, 4-benzodioxines. Eur J Pharm Sci 2019;139:105045.", "ArticleIdList": ["31421253"]}, {"Citation": "Vonk J, Shackelford TK, eds. The Oxford handbook of comparative evolutionary psychology. P. E. Nathan (Editor-in-chief). Oxford Library of Psychology. New York: Oxford University Press; 2012:574."}, {"Citation": "Ghorab MM, Ragab FA, Heiba HI, Soliman AM.. Anticancer and radio-sensitizing evaluation of some new sulfonamide derivatives bearing pyridone, thiophene, and hydrazone moieties. Res Chem Intermed 2017;43:4657\u201381."}, {"Citation": "Milas L, Fan Z, Andratschke NH, Ang KK.. Epidermal growth factor receptor and tumor response to radiation: in\u00a0vivo preclinical studies. Int J Radiat Oncol Biol Phys 2004;58:966\u201371.", "ArticleIdList": ["14967457"]}, {"Citation": "Soliman AM, Alqahtani AS, Ghorab MM.. Novel sulphonamide benzoquinazolinones as dual EGFR/HER2 inhibitors, apoptosis inducers and radiosensitizers. J Enzyme Inhib Med Chem 2019;34:1030\u201340.", "ArticleIdList": ["PMC6522976", "31074303"]}, {"Citation": "MacLachlan TK, Sang N, Giordano A.. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit Rev Eukaryot Gene Expr 1995;5:127\u201356.", "ArticleIdList": ["8845581"]}, {"Citation": "Ghorab MM, Alsaid MS, Samir N, et al. . Aromatase inhibitors and apoptotic inducers: design, synthesis, anticancer activity and molecular modeling studies of novel phenothiazine derivatives carrying sulfonamide moiety as hybrid molecules. Eur J Med Chem 2017;134:304\u201315.", "ArticleIdList": ["28427017"]}, {"Citation": "Wang T-H, Wang H-S, Soong Y-K.. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together. Cancer 2000;88:2619\u201328.", "ArticleIdList": ["10861441"]}, {"Citation": "Gorczyca W. Cytometric analyses to distinguish death processes. Endocr Relat Cancer 1999;6:17\u20139.", "ArticleIdList": ["10732781"]}, {"Citation": "Andree H, Reutelingsperger C, Hauptmann R, et al. . Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem 1990;265:4923\u20138.", "ArticleIdList": ["2138622"]}, {"Citation": "Stamos J, Sliwkowski MX, Eigenbrot C.. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J Biol Chem 2002;277:46265\u201372.", "ArticleIdList": ["12196540"]}, {"Citation": "Kramer B, Rarey M, Lengauer T.. Evaluation of the FLEXX incremental construction algorithm for protein\u2013ligand docking. Proteins 1999;37:228\u201341.", "ArticleIdList": ["10584068"]}]}], "History": [{"Year": "2020", "Month": "12", "Day": "28", "Hour": "10", "Minute": "13"}, {"Year": "2020", "Month": "12", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "28"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33357002", "PMC7781899", "10.1080/14756366.2020.1854243"]}}]}